π TANDEM Triumph: Dual Power for LDL Cholesterol Reduction!
May 08, 2025β’5 min
Episode description
π TANDEM Trial: Combining Obicetrapib & Ezetimibe for a powerful LDL reduction! π
β -48.6% vs placebo, -27.9% vs Ezetimibe, -16.8% vs Obicetrapib
πͺ Safe, effective, and oral! #Cardiology #LipidManagement #ASCVD
For the best experience, listen in Metacast app for iOS or Android
